Influencing factors of hospitalization costs for lung cancer patients in Wuhan in 2018-2020
10.3969/j.issn.1006-2483.2023.04.015
- VernacularTitle:2018—2020年武汉市肺癌患者住院费用及其影响因素分析
- Author:
Xi CHEN
1
;
Xiaoxue LIU
2
;
Yongbing LAN
2
;
Chuanhua YU
2
;
Xingyuan LIU
3
;
Shengguang PEI
1
Author Information
1. Wuhan Central Hospital , Wuhan , Hubei 430014 , China
2. Wuhan University , Wuhan Hubei 430071 , China
3. Wuhan Health Information Center , Wuhan , Hubei 430022 , China
- Publication Type:Journal Article
- Keywords:
Lung cancer;
Hospitalization costs;
Treatment mode
- From:
Journal of Public Health and Preventive Medicine
2023;34(4):63-66
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summary the hospitalization costs of lung cancer patients, and analyze the influence factors in these patients, and provide basis for controlling hospitalization costs of lung cancer patients. Methods The hospitalization costs data of hospitalized lung cancer cases in Wuhan from 2018 to 2020 were collected from medical records. Nonparametric test was used to analysis the data for single factor analysis. The patients were divided into two groups according on the upper quartile value of hospitalization cost, that is high-cost group (the cost ≥ the upper quartile value) and normal cost group (the cost “four major hospitals in Hubei” respectively. The hospital type is an independent influencing factors, compared with specialized hospital, the OR is 4.726 for general hospital. The hospitalization days is the independent influencing factors, more hospitalization days has high cost. The treatment mode is the independent influencing factors, compared with non-operative treatment, the OR is 556.129, 18.156 and 5.212 for surgical model, radio therapy model and interventional model respectively. Conclusion The age, hospital level, hospital type, hospitalization days and treatment mode are the independent influencing factors of hospitalization costs. To reduce the hospitalization cost of lung cancer patients, we should standardize the diagnosis of lung cancer patients, and focus on standardizing the treatment mode, also considering other influencing factors, such as hospital level, hospital type.